TCL Archive News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements January 27, 2012
TCL Archive NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science October 28, 1994
TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006